We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01695590
Recruitment Status : Unknown
Verified May 2013 by Prolexys Pharmaceuticals.
Recruitment status was:  Recruiting
First Posted : September 28, 2012
Last Update Posted : June 4, 2013
Sponsor:
Information provided by (Responsible Party):
Prolexys Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : March 2014
  Estimated Study Completion Date : September 2014